Surgical strategy for the treatment of medullary thyroid carcinoma

被引:107
|
作者
Fleming, JB
Lee, JE
Bouvet, M
Schultz, PN
Sherman, SI
Sellin, RV
Friend, KE
Burgess, MA
Cote, GJ
Gagel, RF
Evans, DB
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Sect Endocrine Tumor Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Med Specialties Endocrinol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Med Oncol, Houston, TX 77030 USA
关键词
D O I
10.1097/00000658-199911000-00013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To evaluate surgical complications, patterns of lymph node metastases, and calcitonin response to compartment-oriented lymphadenectomy in patients with primary or recurrent; medullary thyroid carcinoma (MTC). Summary Background Data The majority of patients with invasive MTC have metastasis to regional lymph nodes at the time of diagnosis, as evidenced by the frequent finding of persistently elevated calcitonin levels after thyroidectomy and the high rates of recurrence in the cervical lymph nodes reported in retrospective studies. These data have provided the rationale for surgeons to perform a more extensive lymphadenectomy at the time of initial thyroidectomy and to consider reoperative cervical lymphadenectomy in patients with persistently elevated calcitonin levels after thyroidectomy. Methods Forty patients underwent surgery for MTC from 1991 to 1997 (23 sporadic cases, 17 familial cases). Patients were divided into three groups based on whether they had undergone previous thyroidectomy and on the results of standardized staging studies performed after referral to the authors' institution. Group 1 (11 patients) had received no previous surgery; group 2 (13) underwent thyroidectomy before referral and had an elevated calcitonin level without radiologic evidence of local-regional or distant metastases; and group 3 (16) underwent thyroidectomy before referral and had an elevated calcitonin level with radiologic evidence of local-regional recurrence. The central neck compartment was dissected in all patients; preoperative staging and the extent of previous surgery dictated the need for lateral (modified radical) neck dissection. After primary or reoperative surgery, calcitonin levels were assessed. Results All patients had major reductions in postoperative calcitonin levels. Seven (29%) of 24 patients in groups 1 and 2 achieved normal calcitonin values compared with only 1 (8%) of 16 in group 3. Postoperative complications included seven cases (17%) of permanent hypoparathyroidism; five (71%) of these occurred in group 3. There were no iatrogenic recurrent laryngeal nerve injuries; one patient required recurrent nerve resection to achieve complete tumor extirpation. At a median follow-up of 35 months, local recurrence was documented in 5 (13%) of 40 patients. Conclusions Compartment-oriented lymphadenectomy performed early in the course of MTC is safe and may return calcitonin levels to normal in up to 25% of carefully selected patients. However, reoperation for bulky cervical disease (group 3) rarely results in normal calcitonin levels and is associated with a high incidence of permanent hypoparathyroidism.
引用
收藏
页码:697 / 707
页数:11
相关论文
共 50 条
  • [41] Recent advances in treatment of medullary thyroid carcinoma
    Vezzosi, D.
    Bennet, A.
    Caron, P.
    ANNALES D ENDOCRINOLOGIE, 2007, 68 (2-3) : 147 - 153
  • [42] RADIOACTIVE IODINE IN THE TREATMENT OF MEDULLARY CARCINOMA OF THE THYROID
    SAAD, MF
    GUIDO, JJ
    SAMAAN, NA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (01): : 124 - 128
  • [43] Somatostatin analogs in the treatment of medullary thyroid carcinoma
    Díez, JJ
    Iglesias, P
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (09) : 773 - 778
  • [44] Somatostatin analogs in the treatment of medullary thyroid carcinoma
    J. J. Díez
    P. Iglesias
    Journal of Endocrinological Investigation, 2002, 25 : 773 - 778
  • [45] Radioactive iodine treatment in medullary thyroid carcinoma
    Erdogan, MF
    Gursoy, A
    Erdogan, G
    Kamel, N
    NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (04) : 359 - 362
  • [46] The pathogenesis and treatment differences between differentiated thyroid carcinoma and medullary thyroid carcinoma
    Su, Jingyang
    Fu, Yue
    Wang, Menglei
    Yan, Jiang
    Lin, Shengyou
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (10) : 1769 - 1770
  • [47] SURGICAL TREATMENT OF CARCINOMA OF THYROID
    TAYLOR, S
    BRITISH JOURNAL OF SURGERY, 1965, 52 (10) : 740 - +
  • [48] SURGICAL TREATMENT OF THYROID CARCINOMA
    BUCKWALTER, JA
    ARCHIVES OF SURGERY, 1969, 98 (05) : 579 - +
  • [49] THE SURGICAL TREATMENT OF CARCINOMA OF THE THYROID
    CHESTER, ST
    AMERICAN JOURNAL OF SURGERY, 1958, 96 (02): : 272 - 280
  • [50] EXPERIENCE IN THE SURGICAL-MANAGEMENT OF MEDULLARY-THYROID CARCINOMA
    LANNIGAN, FJ
    WATKINSON, JC
    CLARKE, SE
    MAISEY, MN
    SHAHEEN, OH
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 1991, 73 (01) : 27 - 31